Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Solifenacin succinate film-coated tablets (10 mg solifenacin succinate) versus Vesicare® film-coated tablets (10 mg solifenacin succinate), in healthy subjects under fasting condition.

drug protocol number
Feb-17
drug sponsor
SPIMACO ADDWAEIH
drug study
solifenacin succinate
drug trial site
Saudi Ajal
drug status
Ongoing
drug phase